記住我
•• Dodd PJ, Osman M, Cresswell FV, Stadelman AM, Lan NH, Thuong NTT, et al. The global burden of tuberculous meningitis in adults: a modelling study. PLOS Glob Public Health. 2021;1(12):e0000069. PMCID: PMC10021871. Epub 20211208. The most complete estimation of the global burden of TBM to date.
• Stadelman AM, Ellis J, Samuels THA, Mutengesa E, Dobbin J, Ssebambulidde K, et al. Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis. Open Forum Infect Dis. 2020 Aug;7(8):ofaa257. PMCID: PMC7423296. Epub 20200630. The most complete estimation of TBM outcomes in impacted populations to date.
Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis. Lancet HIV. 2022 Apr;9(4):e233-e41. PMCID: PMC8964502. Epub 20220323.
de Lima Corvino DF, Shrestha S, Kosmin AR. Tuberculosis Screening. StatPearls. Treasure Island (FL) 2023.
Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992 Mar 5;326(10):668-72. Epub 1992/03/05.
Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. Journal of acquired immune deficiency syndromes. 2011 Mar 1;56(3):230-8. PMCID: PMC3383328.
Geremew D, Melku M, Endalamaw A, Woldu B, Fasil A, Negash M, et al. Tuberculosis and its association with CD4(+) T cell count among adult HIV positive patients in Ethiopian settings: a systematic review and meta-analysis. BMC infectious diseases. 2020 May 7;20(1):325. PMCID: PMC7204319. Epub 20200507.
Date A, Modi S. TB screening among people living with HIV/AIDS in resource-limited settings. J Acquir Immune Defic Syndr. 2015 Apr 15;68(Suppl 3):S270–3.
Article CAS PubMed Google Scholar
Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018 Jul 28;392(10144):292-301. PMCID: PMC6078909. Epub 20180720.
Organization WH. WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease: World Health Organization,; 2021 [Available from: https://www.who.int/publications/i/item/9789240022676.
Marais S, Thwaites G, Schoeman JF, Torok ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. The Lancet infectious diseases. 2010 Nov;10(11):803-12. Epub 20100906.
Bahr NC, Meintjes G, Boulware DR. Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. J Med Microbiol. 2019 May;68(5):755-60. PMCID: PMC7176281. Epub 20190417.
Nuwagira E, Huppler Hullsiek K, Jjunju S, Rutakingirwa M, Kasibante J, Tadeo KK, et al. Diagnostic and prognostic value of cerebrospinal fluid lactate and glucose in HIV-associated tuberculosis meningitis. Microbiol Spectr. 2022 Aug 31;10(4):e0161822. PMCID: PMC9430741. Epub 20220621.
Ssebambulidde K, Gakuru J, Ellis J, Cresswell FV, Bahr NC. Improving technology to diagnose tuberculous meningitis: are we there yet? Front Neurol. 2022;13:892224. PMCID: PMC9195574. Epub 20220530.
Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002 Oct 26;360(9342):1287-92. Epub 2002/11/05.
Stadelman AM, Ssebambulidde K, Buller A, Tugume L, Yuquimpo K, Bakker CJ, et al. Cerebrospinal fluid AFB smear in adults with tuberculous meningitis: a systematic review and diagnostic test accuracy meta-analysis. Tuberculosis (Edinb). 2022 Jul;135:102230. PMCID: PMC9378497. Epub 20220624.
Wilkinson RJ, Rohlwink U, Misra UK, van Crevel R, Mai NTH, Dooley KE, et al. Tuberculous meningitis. Nat Rev Neurol. 2017 Oct;13(10):581-98. Epub 20170908.
Patel VB, Connolly C, Singh R, Lenders L, Matinyenya B, Theron G, et al. Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis. Journal of clinical microbiology. 2014 Oct;52(10):3777-80. PMCID: PMC4187777. Epub 20140723.
Nagdev KJ, Kashyap RS, Parida MM, Kapgate RC, Purohit HJ, Taori GM, Daginawala HF. Loop-mediated isothermal amplification for rapid and reliable diagnosis of tuberculous meningitis. Journal of clinical microbiology. 2011 May;49(5):1861-5. PMCID: PMC3122663. Epub 20110316.
Modi M, Sharma K, Sharma M, Sharma A, Sharma N, Sharma S, et al. Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis. Intl J Tuberculosis Lung Disease Official J Intl Union Tuberculosis Lung Disease. 2016 May;20(5):625–30.
Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, et al. The New Xpert MTB/RIF Ultra: Improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio. 2017 Aug 29;8(4). PMCID: PMC5574709. Epub 20170829.
Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. The Lancet infectious diseases. 2018 Jan;18(1):68-75. PMCID: PMC5739874. Epub 20170914.
Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD012768. PMCID: PMC8078545. Epub 20210115.
Bahr NC, Tugume L, Rajasingham R, Kiggundu R, Williams DA, Morawski B, et al. Improved diagnostic sensitivity for tuberculous meningitis with Xpert((R)) MTB/RIF of centrifuged CSF. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2015 Oct;19(10):1209-15. PMCID: PMC4768484. Epub 2015/10/16.
Donovan J, Cresswell FV, Thuong NTT, Boulware DR, Thwaites GE, Bahr NC, Tuberculous Meningitis International Research C. Xpert MTB/RIF Ultra for the diagnosis of tuberculous meningitis: a small step forward. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020 Nov 5;71(8):2002-5. PMCID: PMC7643749. Epub 2020/06/17.
Bahr NC, Marais S, Caws M, van Crevel R, Wilkinson RJ, Tyagi JS, et al. GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016 May 1;62(9):1133-5. PMCID: PMC4826457. Epub 20160310.
Sharma K, Sharma M, Modi M, Singla N, Sharma A, Sharma A, et al. Comparative analysis of Truenat MTB Plus and Xpert((R)) Ultra in diagnosing tuberculous meningitis. Intl J Tuberculosis Lung Disease Official J Intl Union Tuberculosis Lung Disease. 2021 Aug 1;25(8):626–31.
• Ramachandran PS, Ramesh A, Creswell FV, Wapniarski A, Narendra R, Quinn CM, et al. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics. Nat Commun. 2022 Mar 30;13(1):1675. PMCID: PMC8967864. Epub 20220330. Study integrating metagenomic next-generation sequencing and RNA sequencing data for the diagnosis of TBM.
Ai JW, Zhou X, Xu T, Yang M, Chen Y, He GQ, et al. CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis. Emerg Microbes Infect. 2019;8(1):1361-9. PMCID: PMC6758691.
Huerga H, Cossa L, Manhica I, Bastard M, Telnov A, Molfino L, Sanchez-Padilla E. Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for diagnosing tuberculosis in severely immunocompromised HIV-positive ambulatory patients. The American journal of tropical medicine and hygiene. 2020 Mar;102(3):562-6. PMCID: PMC7056443.
Kwizera R, Cresswell FV, Mugumya G, Okirwoth M, Kagimu E, Bangdiwala AS, et al. Performance of Lipoarabinomannan Assay using cerebrospinal fluid for the diagnosis of tuberculous meningitis among HIV patients. Wellcome Open Res. 2019;4:123. PMCID: PMC6749932. Epub 20190930.
Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, et al. Prospective cohort study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for diagnosis of tuberculous meningitis in Zambia. Journal of clinical microbiology. 2019 Aug;57(8). PMCID: PMC6663887. Epub 20190726.
Broger T, Sossen B, du Toit E, Kerkhoff AD, Schutz C, Ivanova Reipold E, et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study. The Lancet infectious diseases. 2019 Aug;19(8):852-61. PMCID: PMC6656794. Epub 20190530.
•• Quinn CM, Kagimu E, Okirworth M, Bangdiwala AS, Mugumya G, Ramachandran PS, et al. Fujifilm SILVAMP TB LAM Assay on cerebrospinal fluid for the detection of tuberculous meningitis in adults with human immunodeficiency virus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2021 Nov 2;73(9):e3428-e34. PMCID: PMC8563225. Epub 2021/01/04. First and to do, only, study of FujiLAM assay for TBM, a promising, rapid diagnostic test that requires minimal laboratory infrastructure.
Shi F, Qiu X, Yu M, Huang Y. Tuberculosis-specific antigen stimulated and unstimulated interferon-gamma for tuberculous meningitis diagnosis: a systematic review and meta-analysis. PloS one. 2022;17(8):e0273834. PMCID: PMC9426936. Epub 20220830.
Ye Q, Yan W. Adenosine deaminase from the cerebrospinal fluid for the diagnosis of tuberculous meningitis: a meta-analysis. Tropical medicine & international health: TM & IH. 2023 Mar;28(3):175-85. Epub 20230120.
Corral I, Quereda C, Navas E, Martin-Davila P, Perez-Elias MJ, Casado JL, et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):471-6. Epub 20040513.
Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, et al. Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity. Nat Commun. 2019 Aug 21;10(1):3767. PMCID: PMC6704154. Epub 20190821.
Saghazadeh A, Rezaei N. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis. J Interf Cytokine Res. 2022 Mar;42(3):95–107.
Ardiansyah E, Avila-Pacheco J, Nhat LTH, Dian S, Vinh DN, Hai HT, et al. Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis. Elife. 2023 May 9;12. PMCID: PMC10181821. Epub 20230509.
Bahr NC, Halupnick R, Linder G, Kiggundu R, Nabeta HW, Williams DA, et al. Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. Biomark Med. 2018 Jul;12(7):707-16. PMCID: PMC6161141. Epub 20180601.
Huang TY, Zhang XX, Wu QL, Peng WG, Zheng GL, Cai YM, et al. Antibody detection tests for early diagnosis in tuberculous meningitis. Int J Infect Dis. 2016 Jul;48:64-9. Epub 20160509.
Botha H, Ackerman C, Candy S, Carr JA, Griffith-Richards S, Bateman KJ. Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis. PloS one. 2012;7(6):e38982. PMCID: PMC3387202. Epub 20120629.
Azeemuddin M, Alvi A, Sayani R, Khan MK, Farooq S, Beg MA, et al. Neuroimaging findings in tuberculosis: a single-center experience in 559 cases. J Neuroimaging. 2019 Sep;29(5):657-68. Epub 20190521.
Marais S, Pepper DJ, Marais BJ, Torok ME. HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges. Tuberculosis (Edinb). 2010 Nov;90(6):367-74. Epub 20100928.
Chaidir L, Annisa J, Dian S, Parwati I, Alisjahbana A, Purnama F, et al. Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia. Diagnostic microbiology and infectious disease. 2018 May;91(1):42-6. Epub 20180109.
Thwaites GE, Chau TT, Caws M, Phu NH, Chuong LV, Sinh DX, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Intl J Tuberculosis Lung Disease Official J Intl Union Tuberculosis Lung Disease. 2002 Oct;6(10):865–71.
Cecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, Perez M, et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Intl J Tuberculosis Lung Disease Official J Intl Union Tuberculosis Lung Disease 2009 Feb;13(2):269-71. Epub 2009/01/17.
Croda MG, Vidal JE, Hernandez AV, Dal Molin T, Gualberto FA, de Oliveira AC. Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis. 2010 Jul;14(7):e586-91. Epub 20091214.
Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc FX, et al. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health. 2023 Jun;11(6):e903–e16.
Article CAS PubMed Google Scholar
Donovan J, Thu DDA, Phu NH, Dung VTM, Quang TP, Nghia HDT, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. The Lancet infectious diseases. 2020 Mar;20(3):299-307. PMCID: PMC7045088. Epub 20200107.
Pradhan NN, Paradkar MS, Kagal A, Valvi C, Kinikar A, Khwaja S, et al. Performance of Xpert((R)) MTB/RIF and Xpert((R)) Ultra for the diagnosis of tuberculous meningitis in children. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2022 Apr 1;26(4):317-25. PMCID: PMC9592112.
Manyelo CM, Solomons RS, Snyders CI, Kidd M, Kooblal Y, Leukes VN, et al. Validation of host cerebrospinal fluid protein biomarkers for early diagnosis of tuberculous meningitis in children: a replication and new biosignature discovery study. Biomarkers. 2022 Sep;27(6):549-61. Epub 20220512.
Soria J, Chiappe A, Gallardo J, Zunt JR, Lescano AG. Tuberculous meningitis: impact of timing of treatment initiation on mortality. Open Forum Infect Dis. 2021 Jul;8(7):ofab345. PMCID: PMC8297700. Epub 20210630.
Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection S. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. The Journal of infection. 2009 Sep;59(3):167-87. Epub 20090704.
Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011 Apr;24(2):351-76. PMCID: PMC3122491.
Vinnard C, Macgregor RR. Tuberculous meningitis in HIV-infected individuals. Current HIV/AIDS reports. 2009 Aug;6(3):139-45. PMCID: PMC3131531.
Seddon JA, Tugume L, Solomons R, Prasad K, Bahr NC, Tuberculous Meningitis International Research C. The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res. 2019;4:167. PMCID: PMC7029758. Epub 20191105.
Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet neurology. 2013 Oct;12(10):999-1010. Epub 20130823.
Cocchi C, Pasquinucci G. Treatment of tuberculous meningitis; a summary of 3 years’ experience at Florence. Bull World Health Organ. 1950;3(2):215-64. PMCID: PMC2553940.
Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003 Feb 15;167(4):603–62.
Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. The Journal of infectious diseases. 2005 Jul 1;192(1):79-88. Epub 20050520.
Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Maher D, Salaniponi FM. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet. 2001 May 12;357(9267):1519–23.
Article CAS PubMed Google Scholar
Ellard GA, Humphries MJ, Gabriel M, Teoh R. Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis. Br Med J (Clin Res Ed). 1987 Jan 31;294(6567):284-5. PMCID: PMC1245297.
• World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment: World Health Organization,; 2022 [Available from: https://www.who.int/publications/i/item/9789240048126. Current WHO TB treatment guidelines.
Di Paolo A, Gori G, Tascini C, Danesi R, Del Tacca M. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. Clin Pharmacokinet. 2013 Jul;52(7):511–42.
Marais S, Cresswell FV, Hamers RL, Te Brake LHM, Ganiem AR, Imran D, et al. High dose oral rifampicin to improve survival from adult tuberculous meningitis: a randomised placebo-controlled double-blinded phase III trial (the HARVEST study). Wellcome Open Res. 2019;4:190. PMCID: PMC7542255. Epub 20200825.
• Cresswell FV, Meya DB, Kagimu E, Grint D, Te Brake L, Kasibante J, et al. High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV)-positive Ugandan adults: a phase II open-label randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Sep 7;73(5):876-84. PMCID: PMC8423465. Phase two study using high dose rifampin for TBM.
Chow FC. Adjunctive linezolid for the treatment of tuberculous meningitis (ALTER) ClinicalTrials.gov: U.S. National Library of Medicine; 2022 [Available from: https://clinicaltrials.gov/ct2/show/NCT04021121?term=ALTER&cond=TB+meningitis&draw=2&rank=1.
Intense TBM. Intense TBM Clinical Trial 2023 [Available from: https://intense-tbm.org/clinical-trial/.
Heemskerk AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, Nguyen LH, Do TDA, et al. Clinical outcomes of patients with drug-resistant tuberculous meningitis treated with an intensified antituberculosis regimen. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2017 Jul 1;65(1):20-8. PMCID: PMC5850451.
Heemskerk AD, Bang ND, Mai NT, Chau TT, Phu NH, Loc PP, et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med. 2016 Jan 14;374(2):124–34.
Article CAS PubMed Google Scholar
Ding J, Thuy Thuong Thuong N, Pham TV, Heemskerk D, Pouplin T, Tran CTH, et al. Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis. Clin Pharmacol Ther. 2020 Apr;107(4):1023-33. PMCID: PMC7158205. Epub 20200229.
Liu L, Xu Y, Shea C, Fowler JS, Hooker JM, Tonge PJ. Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem. 2010 Apr 8;53(7):2882-91. PMCID: PMC2866172.
Tucker EW, Pieterse L, Zimmerman MD, Udwadia ZF, Peloquin CA, Gler MT, et al. Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans. Antimicrob Agents Chemother. 2019 Oct;63(10). PMCID: PMC6761520. Epub 20190923.
Shibata M, Shimokawa Y, Sasahara K, Yoda N, Sasabe H, Suzuki M, Umehara K. Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis. Biopharm Drug Dispos. 2017 May;38(4):301-12. Epub 20170308.
Bratkowska D, Shobo A, Singh S, L AB, Kruger HG, Maguire GE, Govender T. Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Apr 15;988:187-94. Epub 20150309.
Shobo A, Bratkowska D, Baijnath S, Naiker S, Somboro AM, Bester LA, et al. Tissue distribution of pretomanid in rat brain via mass spectrometry imaging. Xenobiotica. 2016;46(3):247-52. Epub 20150724.
Stadler JAM, Maartens G, Meintjes G, Wasserman S. Clofazimine for the treatment of tuberculosis. Front Pharmacol. 2023;14:1100488. PMCID: PMC9932205. Epub 20230202.
Baijnath S, Moodley C, Ngcobo B, Singh SD, Kruger HG, Arvidsson PI, et al. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model. Int J Antimicrob Agents. 2018 Jan;51(1):77-81. Epub 20170824.
Baijnath S, Naiker S, Shobo A, Moodley C, Adamson J, Ngcobo B, et al. Evidence for the presence of clofazimine and its distribution in the healthy mouse brain. J Mol Histol. 2015 Oct;46(4-5):439-42. Epub 20150725.
Baik J, Stringer KA, Mane G, Rosania GR. Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response. Antimicrob Agents Chemother. 2013 Mar;57(3):1218-30. PMCID: PMC3591914. Epub 20121221.
• Kempker RR, Smith AGC, Avaliani T, Gujabidze M, Bakuradze T, Sabanadze S, et al. Cycloserine and linezolid for tuberculosis meningitis: pharmacokinetic evidence of potential usefulness. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2022 Sep 10;75(4):682-9. PMCID: PMC9464073. Pharmacokinetic study regarding the potential use of linezolid for TBM.
Upton CM, Steele CI, Maartens G, Diacon AH, Wiesner L, Dooley KE. Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). J Antimicrob Chemother. 2022 May 29;77(6):1720-4. PMCID: PMC9633714.
van Heeswijk RP, Dannemann B, Hoetelmans RM. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions. J Antimicrob Chemother. 2014 Sep;69(9):2310-8. Epub 20140523.
Davis AG, Rohlwink UK, Proust A, Figaji AA, Wilkinson RJ. The pathogenesis of tuberculous meningitis. J Leukoc Biol. 2019 Feb;105(2):267-80. PMCID: PMC6355360. Epub 20190115.
Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014 Summer;14(2):203-7. PMCID: PMC4052587.
Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004 Oct 21;351(17):1741-51. Epub 2004/10/22.
Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016 Apr 28;4(4):CD002244. PMCID: PMC4916936. Epub 20160428.
•• Donovan J, Bang ND, Imran D, Nghia HDT, Burhan E, Huong DTT, et al. Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults. N Engl J Med. 2023 Oct 12;389(15):1357–67. A randomized trial investigating the potential benefit of corticosteroids specifically for people living with HIV.
Selvaraj JU, Sujalini BB, Rohitson MS, George AA, Arvind VH, Mishra AK. Identification of predictors of cerebrovascular infarcts in patients with tuberculous meningitis. Int J Mycobacteriol. 2020 Jul-Sep;9(3):303–8.
Wen L, Li M, Xu T, Yu X, Wang L, Li K. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. Journal of neurology. 2019 Dec;266(12):3009-21. Epub 20190904.
Richman IB, Owens DK. Aspirin for primary prevention. Med Clin North Am. 2017 Jul;101(4):713–24.
Botting RM. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. Pharmacol Rep. 2010 May-Jun;62(3):518–25.
Article CAS PubMed Google Scholar
Davis AG, Donovan J, Bremer M, Van Toorn R, Schoeman J, Dadabhoy A, et al. Host Directed Therapies for Tuberculous Meningitis. Wellcome Open Res. 2020;5:292. PMCID: PMC8792876. Epub 20210701.
Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci. 2010 Jun 15;293(1-2):12-7. Epub 20100424.
Mai NTH, Dobbs N, Phu NH, Colas RA, Thao LTP, Thuong NTT, et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. Elife. 2018 Feb 27;7. PMCID: PMC5862527. Epub 20180227.
Misra UK, Kalita J, Sagar B, Bhoi SK. Does adjunctive corticosteroid and aspirin therapy improve the outcome of tuberculous meningitis? Neurol India. 2018 Nov-Dec;66(6):1672–7.
Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P. The role of aspirin in childhood tuberculous meningitis. J Child Neurol. 2011 Aug;26(8):956-62. Epub 20110531.
Marais BJ, Cheong E, Fernando S, Daniel S, Watts MR, Berglund LJ, et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions. Open Forum Infect Dis. 2021 Jan;8(1):ofaa604. PMCID: PMC7846119. Epub 20201228.
van Toorn R, Solomons RS, Seddon JA, Schoeman JF. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clinical Infectious Diseases Official Publication Infectious Diseas Soc Am. 2021 Mar 1;72(5):e136–e45.
Abo YN, Curtis N, Osowicki J, Haeusler G, Purcell R, Kadambari S, et al. Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis. J Pediatric Infect Dis Soc. 2021 Dec 31;10(12):1087–91.
留言 (0)